Vaccination against mutated protein tested in brain tumor patients for the first time

GSTDTAP > 资源环境科学

	Vaccination against mutated protein tested in brain tumor patients for the first time
	admin
	2021-03-24
发布年	2021
语种	英语
国家	德国
领域	资源环境
正文(英文)	Tumor vaccines can help the body fight cancer. Mutations in the tumor genome often lead to protein changes that are typical of cancer. A vaccine can alert the patients' immune system to these mutated proteins. For the first time, physicians and cancer researchers from Heidelberg and Mannheim have now carried out a clinical trial to test a mutation-specific vaccine against malignant brain tumors. The vaccine proved to be safe and triggered the desired immune response in the tumor tissue, as the team now reports in the journal Nature.Joint press release by the German Cancer Research Center, University Medicine Mannheim, Heidelberg University Hospital, and the National Center for Tumor Diseases (NCT) Heidelberg
URL	查看原文
来源平台	Helmholtz Association
文献类型	新闻
条目标识符	http://119.78.100.173/C666/handle/2XK7JSWQ/319770
专题	资源环境科学
推荐引用方式 GB/T 7714	admin. Vaccination against mutated protein tested in brain tumor patients for the first time. 2021.